<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03019367</url>
  </required_header>
  <id_info>
    <org_study_id>PREMOD2</org_study_id>
    <secondary_id>1R01HD088646-01A1</secondary_id>
    <nct_id>NCT03019367</nct_id>
  </id_info>
  <brief_title>Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2</brief_title>
  <acronym>PREMOD2</acronym>
  <official_title>Premature Infants Receiving Milking or Delayed Cord Clamping: Randomized Controlled Multicenter Non-inferiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sharp HealthCare</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sharp Mary Birch Hospital for Women &amp; Newborns</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Providence Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College Cork</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Christiana Care Health Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sharp Grossmont Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Mississippi Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sharp HealthCare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done to find out whether umbilical cord milking (UCM) is at least as good
      as or better than delayed cord clamping (DCC) to reduce bleeding in the brain or prevent
      death in premature newborns. The investigators will study short and long term outcomes of
      infants delivered before 32 weeks gestation that receive either UCM or DCC.

      * The trial was stopped by the DSMB for safety in the small strata. They consequently allowed
      for continuation of the trial in infants 29-32+6 wk GA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim 1. Compare the incidence of severe intraventricular hemorrhage (IVH) and/or death in
      premature newborns &lt;/=33 weeks gestational age (GA) delivered by C/S receiving UCM to those
      receiving DCC.

      Hypothesis1: First demonstrate infants in the UCM group are not inferior to the DCC group
      (reject H10).

      Hypothesis2: If H1 is true, demonstrate lower incidence of severe IVH and/or death in UCM
      infants compared to DCC.

      Aim 2. Compare the safety and efficacy profiles of premature newborns &lt;/=33 weeks GA
      delivered by C/S receiving UCM vs. DCC during their hospitalization.

      Hypothesis3: UCM group will have a decreased need for resuscitation interventions with no
      differences in bilirubin or polycythemia compared to DCC.

      Hypothesis4: UCM group will have improved blood pressures in the first 24 hours of life
      compared to DCC.

      Aim 3 (exploratory). To compare the outcomes of premature newborns &lt;/=33 weeks GA delivered
      by C/S (Cesarean section) (from Aims 1 and 2) with those born by V/D (vaginal delivery)
      receiving UCM or DCC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 6, 2017</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>It is not possible to blind the delivering obstetrician, however all other caregivers will be blinded. The procedure will be documented as &quot;placental transfusion&quot; in the delivery summary or admission-progress notes and all study assessments whether primary (head US) or secondary (neurodevelopmental exams) will be performed by blinded team members.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of severe IVH or death</measure>
    <time_frame>Through study completion at death or discharge, up to 6 months corrected gestational age (CGA)</time_frame>
    <description>Severe intraventricular hemorrhage of grade 3 or 4 or death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All Grade IVH</measure>
    <time_frame>Through study completion at discharge, up to 6 months corrected gestational age (CGA)</time_frame>
    <description>Any intraventricular hemorrhage (grades 1-4)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe IVH (Grade 3 or 4)</measure>
    <time_frame>Through study completion at discharge, up to 6 months corrected gestational age (CGA)</time_frame>
    <description>Severe intraventricular hemorrhage (bleeding in the brain parenchyma and/or ventricular dilation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin/Hematocrit at 4 hours</measure>
    <time_frame>4 +/- 2 hours of life</time_frame>
    <description>hemoglobin/hematocrit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Severe IVH or death in infants &lt;28 weeks gestation</measure>
    <time_frame>Through study completion at discharge, up to 6 months corrected gestational age (CGA)</time_frame>
    <description>Severe intraventricular hemorrhage (grade 3 or 4) in infants born under 28 weeks gestational age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delivery room interventions</measure>
    <time_frame>In the first 10 minutes of life</time_frame>
    <description>Resuscitation interventions including positive pressure ventilation, continuous positive airway pressure, intubation, chest compressions and medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressures in the first 24 hours of life</measure>
    <time_frame>In the first 24 hours of life</time_frame>
    <description>Blood pressure on admission, 6, 12, 18 and 24 hours of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Intraventricular Haemorrhage Neonatal</condition>
  <condition>Death; Neonatal</condition>
  <arm_group>
    <arm_group_label>Umbilical cord milking UCM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Milking the umbilical cord 4 times towards the infant at a speed of 20cm/2seconds.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed cord clamping DCC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Delayed clamping of the umbilical cord for at least 60 seconds.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Umbilical cord milking UCM</intervention_name>
    <description>At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before it is clamped. This procedure infuses a placental transfusion of blood into the preterm neonate and can be done in 15-20 seconds.</description>
    <arm_group_label>Umbilical cord milking UCM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Delayed cord clamping DCC</intervention_name>
    <description>At delivery, delayed cord clamping will be performed by having the delivering obstetrician delay clamping of the umbilical cord for at least 60 seconds.</description>
    <arm_group_label>Delayed cord clamping DCC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  23 to 32 +6 Gestational age (currently enrolling 29 to 32+6 weeks)

          -  Multiples unless monochorionic

        Exclusion Criteria:

          -  Congenital anomalies

          -  Major cardiac defects

          -  Placental abruption or previa with hemorrhage

          -  Cord prolapse

          -  Hydrops

          -  Bleeding Accreta

          -  Monochorionic multiples (i.e. Di/Mo or Mo/Mo twins)

          -  Fetal or maternal risk (i.e. compromise)

          -  Parents declined study

          -  Unlikely to return for 2 yr Follow Up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>23 Weeks</minimum_age>
    <maximum_age>33 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anup C Katheria, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sharp HealthCare</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anup C Katheria, MD</last_name>
    <phone>858 939-4170</phone>
    <email>anup.katheria@sharp.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kathy M Arnell, RN</last_name>
    <phone>858 939-4966</phone>
    <email>kathy.arnell@sharp.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294-0004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wally Carlo, MD</last_name>
      <email>wcarlo@peds.uab.edu</email>
    </contact>
    <contact_backup>
      <last_name>Akila Subramaniam, MD</last_name>
      <email>asubramaniam@uabmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Loma Linda Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giang Truong, MD</last_name>
      <email>GTTruong@llu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Shareece Davis-Nelson, MD</last_name>
      <email>SHDavis@llu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Giang Truong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shareece Davis-Nelson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharp Grossmont Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anup Katheria, MD</last_name>
      <email>anup.katheria@sharp.com</email>
    </contact>
    <contact_backup>
      <last_name>Kevin Fulford, MD</last_name>
      <email>Kevin.fulford@sharp.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Sharp Mary Birch Hospital for Women and Newborns</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anup Katheria, MD</last_name>
      <phone>858-939-4198</phone>
      <email>anup.katheria@sharp.com</email>
    </contact>
    <contact_backup>
      <last_name>Kathy Arnell, RN</last_name>
      <phone>858 939 4966</phone>
      <email>kathy.arnell@sharp.com</email>
    </contact_backup>
    <investigator>
      <last_name>Anup Katheria, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christiana Care</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Karam, MD</last_name>
      <email>skaram@umc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Providence St. Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225-6603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Kaempf, MD</last_name>
      <email>Joseph.Kaempf@providence.org</email>
    </contact>
    <contact_backup>
      <last_name>Mark Tomlinson, MD</last_name>
      <email>Mark.Tomlinson@providence.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Magee-Womens Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Clark, MD</last_name>
      <email>erin.clark@hsc.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tara DuPont, MD</last_name>
      <email>tara.dupont@hsc.utah.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Governors of University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2R3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Schmolzer, MD</last_name>
      <email>georg.schmoelzer@me.com</email>
    </contact>
    <contact_backup>
      <last_name>Radha Chari, MD</last_name>
      <email>radha.chari@albertahealthservices.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of ULM</name>
      <address>
        <city>Ulm</city>
        <state>Baden-Wurttemberg</state>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helmut Hummler, MD</last_name>
      <email>helmut.hummler@uni-ulm.de</email>
    </contact>
    <contact_backup>
      <last_name>Frank Reister, MD</last_name>
      <email>Frank.reister@uniklinik-ulm.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cork University Maternity Hospital</name>
      <address>
        <city>Cork</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eugene Dempsey, MD</last_name>
      <email>G.Dempsey@ucc.ie</email>
    </contact>
    <contact_backup>
      <last_name>Keelin O'Donoghue, MD</last_name>
      <email>K.Odonoghue@ucc.ie</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.premod2.org</url>
    <description>Website for trial</description>
  </link>
  <link>
    <url>https://clinicaltrials.gov/show/NCT03145142</url>
    <description>NIRS Sub-study PREMOD2</description>
  </link>
  <link>
    <url>http://clinicaltrials.gov/show/nct03476980</url>
    <description>Followup Study-PREMOD2</description>
  </link>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 21, 2016</study_first_submitted>
  <study_first_submitted_qc>January 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2017</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sharp HealthCare</investigator_affiliation>
    <investigator_full_name>Anup Katheria, M.D.</investigator_full_name>
    <investigator_title>Director of Neonatal Research Institute</investigator_title>
  </responsible_party>
  <keyword>Premature infants</keyword>
  <keyword>Umbilical cord milking</keyword>
  <keyword>Delayed cord clamping</keyword>
  <keyword>Intraventricular Hemorrhage</keyword>
  <keyword>Death</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be made available per NICHD requirements (National Institute of Child Health and Human Development).</ipd_description>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>2 years after primary publication</ipd_time_frame>
    <ipd_access_criteria>An archived dataset with documentation will be made available for additional uses by outside investigators, in collaboration with the study investigators. We will work with NICHD program staff to develop a broad data sharing plan over time.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

